INTRODUCTION
Influenza is a human respiratory infection caused by influenza viruses, and spreads worldwide in an annual outbreak or does occasionally in pandemics, resulting in significant morbidity and mortality (Herfst et al., 2012) . The primary event in influenza virus infection is the attachment of virus particles to the host cell surface, which is mediated by the binding of HA to sialylated cell surface receptors on respiratory or intestinal epithelial cells in humans and birds, respectively (Kumlin et al., 2008) . Avian viruses bind preferentially to receptors with α2,3-linked sialic acid moieties, whereas human-adapted viruses are specific for the α2,6
linkage (Connor et al., 1994; Rogers and D'Souza, 1989) . This specificity is key to determination of the host range of each viral strain. Given that the sialic acid that contributes to the binding of HA to the cell surface may be presented on a glycoprotein, many studies have attempted to identify specific IAV receptor protein(s). Such identified proteins include the killer-activating proteins NKp44 and NKp46 in natural killer cells (Achdout et al., 2010; Arnon et al., 2004; Ho et al., 2008; Mandelboim et al., 2001) , as well as the epidermal growth factor receptor in lung epithelial cells (Eierhoff et al., 2010) . However, the binding of IAV to sialylated cell surface proteins does not always result in receptor-mediated internalization (Carroll and Paulson, 1985; Williams and Robertson, 1993) , suggesting that the engagement of specific cellular signaling may be required to initiate virus endocytosis.
IAVs enter host cells via redundant endocytic pathways, including clathrin-mediated endocytosis, clathrin-independent endocytosis, and Macropinocytosis (Chen and Zhuang, 2008; Doxsey et al., 1987; Fujioka et al., 2011; 2013; Matlin et al., 1981; Rust et al., 2004; Sieczkarski and Whittaker, 2002) . It has been previously demonstrated that intracellular Ca 2+ plays a central role in upregulating such endocytic pathways (Fujioka et al., 2013) . Indeed, IAV infection induces Ca 2+ oscillations of host cells, and the infection is markedly attenuated by the chelation of both intracellular and extracellular Ca 2+ by BAPTA-AM and EGTA, respectively (Fujioka et al., 2013) , suggesting that Ca 2+ flux from the outside to the inside of cell may also play a role in the regulation of IAV entry and infection. ]i in host cells, because (1) these channels are expressed at the plasma membrane, (2) their function is modified by sialylation (Ednie and Bennett, 2012), (3) one of the calcium channel blockers (CCBs), verapamil, inhibits IAV replication by an unknown mechanism (Nugent and Shanley, 1984) and (4) extracellular Ca 2+ is also important for the IAV-induced increase in [Ca 2+ ]i (Fujioka et al., 2013) . In this study, we demonstrated that the VDCC Cav1.2 (encoded by the CACNA1C gene) bound to IAV HA. The binding through sialic acid was crucial for IAV infection, entry, and IAV-induced Ca 2+ oscillation. The effect of the CCBs on virus infection was also demonstrated in vitro, ex vivo, and in vivo. Taken together, our analysis revealed that Cav1.2 acts as a key cell surface molecule for IAVs to hijack host cell machinery of endocytosis for their efficient incorporation into host cells. Figures 1D, 1E , S1G, and S1H; Supplementary Movies 1, 2). Moreover, diltiazem also inhibited virus internalization ( Figures 1F and 1G) . Together, these results indicated that VDCCs contribute to IAV entry and subsequent infection.
RESULTS

CCBs
Knockdown of Cav1.2 Inhibits IAV-Induced Ca 2+ Oscillations, IAV Internalization, and
IAV Infection
Among VDCC family members (L-, P/Q-, N-, R-and T-type channels), L-type VDCCs are expressed ubiquitously, including respiratory epithelia (Brennan et al., 2013) , whereas non-L-type channels show neuron-or sinus node-restricted expression patterns (Catterall, 2011; Catterall et al., 2005) . In addition, among L-type channels, whereas Cav1.2 expression has been detected in a range of tissues, Cav1.1, Cav1.3 and Cav1.4 are expressed predominantly in skeletal muscle, neuroendocrine tissues and the retina, respectively (Catterall et al., 2005) .
The copy number of Cav1.2 mRNA was markedly higher than that of Cav1.1, Cav1.3 or Cav1.4 mRNAs in the human cell lines examined in the present study ( Figure S2A ).
Knockdown of Cav1.2 (by up to ~60% as revealed by immunoblot analysis) ( Figure S2B ) in A549 cells by transfection with small interfering RNAs (siRNAs) inhibited PR8-induced Ca 2+ oscillations, virus entry, and virus infection (Figures 2A-C Figures 3A and 3B) . We found that PR8 bound to full-length (FL) Cav1.2 ( Figure 3C ) and that this binding was partially inhibited by treatment with sialidase but not by the Ca 2+ chelator EGTA ( Figure 3C ). These results indicated that sialylation of Cav1.2 is required for IAV binding, whereas Ca 2+ is dispensable. Analysis of membrane fractions of cells expressing truncation mutants of Cav1.2 revealed that IAV preferentially bound to fragment containing segment IV of Cav1.2 ( Figure   3D ). It was recently reported that there are two potential sialylated asparagine residues (N1436 and N1487) in segment IV (Lazniewska and Weiss, 2017) ( Figure 3B ), suggesting that the HA glycoprotein might be responsible for binding of IAV to this fragment. To test this notion more directly, we performed a co-immunoprecipitation assay for HA and Cav1.2.
HA is retained at the plasma membrane or virus surface through the transmembrane region at its COOH-terminus (Mair et al., 2014) , and trimer formation by HA determines the rate of its transport for secretion (Ceriotti and Colman, 1990) . We therefore constructed an expression vector for a form of HA in which the transmembrane region is replaced with a six-histidine (6×His) tag and a foldon domain, a natural trimerization domain from T4 bacteriophage fibritin (Meier et al., 2004) (Figure S3D ). The modified HA protein (HA-His) would be expected to be secreted from cells as a trimer and to contact the cell surface region of Cav1.2.
As expected, HA-His was detected in immunoprecipitates of full-length (FL) Cav1.2 or of fragment III-IV, but not in those of fragment I-II (Figures 3E and 3F) . Given that the membrane-localized fraction of truncation mutants was comparable to that of full-length Cav1.2 ( Figure S3E) , the difference in precipitation might be accounted for by the difference in binding affinity to HA, but not by their localization. The binding of HA to fragment III-IV was partially inhibited by treatment with sialidase, suggesting that HA indeed binds to segment IV (or III) of Cav1.2 through sialylated residues ( Figure S3F ).
HA Bindings to Cav1.2 through Glycosylated Asparagine Residues is Crucial for Calcium Oscillation and Virus Infection
To examine further whether sialylation of Cav1.2 is required for the HA-Cav1.2 interaction, we constructed Cav1.2 mutants in which one or both of the potential sialylated asparagine residues in domain IV was replaced with glutamine (N1436Q, N1487Q and N1436Q + N1487Q). Expression of the wild-type form of fragment III-IV of Cav1.2 in 293T cells gave rise to two distinct bands, only the faster migrating of which was detected in cells expressing the mutants ( Figure S4A ). This result suggested that the slower migrating band (indicated by arrowhead) represented a form of the fragment that was glycosylated at N1436, N1487, or both residues. Indeed, the upper band of the wild-type fragment was no longer evident after treatment with peptide:N-glycosidase F (PNGase F), which inhibits IAV infection (Chu and Whittaker, 2004) , whereas such treatment had no effect on the electrophoretic mobility of the mutants ( Figure S4B ). The binding of HA to the Cav1.2 mutants was attenuated compared with that apparent with the wild-type fragment ( Figure 4A ). The extent of this attenuation was similar to that induced by sialidase treatment (Figures 3C and S3F) , suggesting that sialic acid-dependent binding of Cav1.2 to HA might be dictated by these asparagine residues. Figure S4C ). Given that the glycosylation deficient mutant could be localized at the plasma membrane to a similar extent as the wild-type form (Figure S4D) , it was indicated that glycosylation at N1436 or N1487
(or both residues) of Cav1.2 and the binding of these residues to HA are critical for Ca 2+ -regulated virus infection.
The CCB Diltiazem Inhibits IAV Infection In Vivo and Ex Vivo.
To demonstrate the significance of VDCCs and its inhibition in IAV infection in vivo, we first S5A ); although this effect was less pronounced than that of the anti-influenza drug oseltamivir, the difference in the observed maximal effects of the two drugs was not significant. Diltiazem also inhibited virus replication when the treatment was initiated 1 day after exposure to PR8 ( Figure 6C ), with this effect being similar to that of oseltamivir. To further demonstrate the effectiveness of CCB to protect against lethal infection, mice were challenged with a higher dose of PR8 (10 4 PFU) and monitored for survival and body weight changes ( Figures 6D and 6E ). Diltiazem administration significantly prolonged survival and allowed the recovery of the survivors. Taken together, the CCB was thus effective as both a prophylactic and therapeutic agent to a wide range of doses of infection.
epithelial cells. To this aim, the human bronchial epithelial cell line BEAS-2B was recruited.
BEAS-2B cells were known to form spheroid (mimics of alveoli) and epithelial monolayer (mimics of bronchial epithelium) when cultured "on" and "in" Matrigel (Shen et al., 2015) .
After formation of either spheroid ( Figure S5B ) or monolayer ( Figure S5C) , the cells were then pre-treated with diltiazem and exposed to PR8. In both structures, IAV NP-positive cells were dramatically decreased by the treatment, affirming that the CCB was also effective human respiratory epithelial cells.
DISCUSSION
In this study, we have shown that Cav1.2 bound to IAV HA and functional analysis also Therefore, identification of a protein(s) that is critical for IAV adsorption to host cells and subsequent infection has yet to be eagerly anticipated. One of the reason why such a wide variety of proteins are identified as a binding partner for HA, but are not involved in IAV entry and infection, might be accounted partly for by the abundance of sialylated proteins on the cell surface; viz. when there is an abundant protein that is modified by α2,3-linked or α2,6-linked sialic acids at many sites and is irrelevant to IAV infection, the sensitivity to detect the real targets can be decreased markedly. Another possible reason that makes molecular identification difficult might be accounted for by non-specific or sialic acidindependent binding to HA. In this study, binding of glycosylation-deficient mutants of Cav1.2 was significantly reduced (by ~40%) than that of wild type, but not abolished completely ( Figure 4A ), suggesting that Cav1.2 may also bind to HA at multiple extracellular regions in a manner independent of sialic acid. Accordingly, sialidase treatment also displayed partial inhibitory effect on the binding (Figures 3C and S3F ).
Although we here show that IAV bound to N1436 and N1487 residues in segment IV of Cav1.2 to evoke host cell Ca 2+ signaling and facilitate infection ( Figures 4B and S4C ), the molecular mechanism through which the binding induces Ca 2+ influx has not been clarified.
The possible mechanisms include: 1) an increase in channel conductance, 2) an increase in opening probability of the channel, and 3) decreased interaction of α1 and other subunits. VDCC is a multimeric complex that consists of α1, α2, β, δ, and γ (Catterall, 2011; Catterall et al., 2005) . In particular, interaction of α1 subunit to β subunit through highly Although significance of glycosylation at these sites is unclear, it is therefore possible that the sialylated channels other than Cav1.2 also bind to HA and play a role in influenza virus 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Mouse experiments were approved and conducted in accordance with the guidelines established by the Hokkaido University Committee and National Institute of Infectious Diseases on Animal Care and Use. Male C57BL/6J or female BALB/c mice were housed under specific pathogen-free conditions at 21°C and 31% humidity. At least four mice for each group at 6-8 weeks of age were subjected to experiments.
Cell lines
Cos 
Fluorescent labeling of viruses
For preparation of fluorescently labeled PR8, 1 ml of purified virus suspension (0.4 mg/ml) was incubated with 100 μM DiD stock solution in the dark for 1 h at room temperature (Nanbo et al., 2010) .
Plaque assay
A plaque assay was performed as described previously (Pleschka et al., 2001; Yoshida et al., 2009 ). In brief, confluent monolayers of MDCK cells in 12-well plates were inoculated with the conditioned medium of virus-infected cells or directly with virus suspension. After culture for 1 h, the culture supernatants were removed and the cells were overlaid with MEM containing 1% Bacto-agar and trypsin (5 μg/ml). Plaques were counted after incubation of the cells at 35°C under 5% CO2 for 2 days.
Immunofluorescence-based virus internalization and infection assays
Immunofluorescence-based virus internalization and infection assays were performed as described previously (Fujioka et al., 2013) . In brief, serum-deprived cells were either treated 
Fluorescence microscopy and FRET analysis
FRET imaging and data analysis were performed essentially as described previously (Fujioka et al., 2013; Ohba et al., 2003) . To determine the cell surface expression levels of VDCCs, 293T cells were transfected with expression vectors for either wild-type form, truncation form, or glycosylation-deficient mutant form of FLAG-tagged Cav1.2, along with that for Sirius-CAAX (marker for plasma membrane) for 24h. The cells were then subjected to immunofluorescence with the use of an anti-FLAG antibody. Mask images for plasma membrane were generated by binary images of Sirius-CAAX, whereas those for entire cell area were generated by filling the inside of CAAX-positive region. Fluorescence intensities in the plasma membrane region and entire cell region were thereby quantified, assumed as the expression level of Cav1.2 in each region, and plotted.
Immunoblot analysis
Unless otherwise specified, cells were lysed in lysis buffer (50 mM Tris-HCl (pH 7.4), 150
mM NaCl, 0.25% Fos-choline, 1 mM CaCl2, 1 mM MgCl2, 1 mM phenylmethylsulphonyl fluoride, 1 mM Na3VO4, cOmplete Protease Inhibitor Cocktail (Sigma-Aldrich)) for 30 min on ice. The lysates were centrifuged at 20,000 × g for 10 min at 4°C, and the resulting supernatants were subjected to SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad) and subjected to immunoblot analysis. Immune complexes were detected with the use of ECL Western
Blotting Detection Reagent (GE Healthcare) and an LAS-1000UVmini image analyzer (Fujifilm).
Immunoprecipitation
Cells were lysed and the lysates centrifuged as described for immunoblot analysis, and the resulting supernatants were incubated with primary antibodies for 1 h at 4°C with gentle rotation before the addition of protein G-or protein A-Sepharose beads (GE Healthcare) and further incubation for 1 h. The bead-bound immune complexes were isolated by centrifugation, washed twice with lysis buffer, eluted in SDS sample buffer and subjected to immunoblot analysis.
Membrane binding assay
293T cells were transfected for 24 h with expression vectors for full-length or fragments of Cav1.2 and then resuspended in Tris-buffered saline containing 1 mM Na3VO4. A membrane fraction of the cells was prepared by freeze-thawing and subsequent centrifugation at 20,400
× g for 10 min at 4°C and was incubated for 12 h at 4°C in a 96-well plate coated with antibodies to Cav1.2 (AB_2039771, Alomone Labs). After washing with Tris-buffered saline containing 1 mM Na3VO4, the wells of the plate were further incubated with PR8 for 1 h at 4°C. After extensive washing, the material adsorbed to each well was eluted in SDS sample buffer and subjected to immunoblot analysis.
RNA interference
The siRNAs targeting human Cav1.2 mRNA (siCav1.2#2, Hs_Cav1.2_2; siCav1.2#13, Hs_Cav1.2_13) were obtained from Qiagen and were introduced into cells by transient transfection with the use of the Lipofectamine RNAiMax reagent (Thermo Fisher Scientific).
AllStars Negative Control siRNA (Qiagen) was used as a control.
RNA isolation, RT and quantitative PCR analysis
Total RNA was isolated from cells with the use of an RNeasy Mini Kit (Qiagen), and portions of the RNA (2.0 μg) were subjected to RT with SuperScript VILO reverse transcriptase (Thermo Fisher Scientific). Quantitative PCR analysis was performed with the use of a
StepOne real-time PCR system (Thermo Fisher Scientific) and the following primers: Cav1.1-F and Cav1.1-R, Cav1.2-F and Cav1.2-R, Cav1.3-F and Cav1.3-R, Cav1.4-F and Cav1.4-R.
The copy number of each Ca 2+ channel was then determined by extrapolation from a calibration curve that was obtained by qPCR with calibrator plasmids as a template.
3D culture
BEAS-2B cells (3 × 10 4 ) were cultured on or in Matrigel (BD-Discovery Labware) in a 35 mm glass-based dish for 5 days. After confirming monolayer or spheroid formation, the cells were further cultured in the presence of absence of diltiazem for 2 h, exposed to PR8 at an MOI of 1 PFU/cell, and subjected to immunofluorescence with the use of antibodies to IAV NP and Cav1.2. Nuclei were counterstained with Hoechst33342. The samples were observed under confocal microscopy.
Animal experiments
Six-week-old male C57BL/6J mice and eight-week-old female BALB/c mice were infected by direct delivery of PR8 (50-3 × 10 4 PFU) to the nares with a micropipette under isoflurane anesthesia, as described previously (Edenborough et al., 2012; Ng et al., 2010) . The mice were housed separately for 3 days after virus exposure. Diltiazem (10 or 20 mg/kg/day) or oseltamivir (40 mg/kg/day) was administered intranasally or intraperitoneally beginning either 1 day before or 1 day after virus exposure. Nasal lavage fluid was collected 3 days after virus exposure and was assayed for the amount of infectious virus with the immunofluorescence-based infection assay. To monitor survival and body weight changes at lethal dose of IAV infection, at least six mice were infected with PR8 (10 4 PFU) as described above. The mice were housed and monitored separately for 14 days after virus exposure.
Diltiazem (20 mg/kg/day) or oseltamivir (40 mg/kg/day) was administered intranasally or intraperitoneally, respectively, beginning 1 day before virus exposure.
To perform immunohistochemical experiments, mice were euthanized at 2 days postinfection. Excised tissues preserved in 4% paraformaldehyde for 12 h were subsequently processed for paraffin embedding and cut into 3-μm-thick sections. One section from each tissue sample was stained using a standard hematoxylin and eosin procedure, and the others were subjected to immunohistochemistry. For visualization of replicated influenza viruses, a rabbit polyclonal NP antibody (Iwasaki et al., 1999) was used as a primary antibody after heat-mediated antigen retrieval in citrate buffer at 121ºC for 10 min. Immunohistochemistry for Cav proteins was performed with a rabbit polyclonal anti-panCav α antibody (AB_2039762, Alomone Labs) as a primary antibody after antigen retrieval in 0.025% trypsin solution at 37ºC for 30 min. A peroxidase-labeled polymer-conjugated anti-rabbit immunoglobulin (Dako) was used as a secondary antibody. Immune complexes were visualized by means of 3,3'-diaminobenzidine tetrahydrochloride staining. Hematoxylin (Modified Mayer's) was used as a nuclear counterstain.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantitative data are presented as means ± s.e.m. from at least three independent experiments (unless indicated otherwise) and were compared by Student's t test (between two conditions) or by one-way analysis of variance (ANOVA) followed by Dunnett's post-hoc analysis (among multiple conditions), log rank test (Figure 6D ) or Mauchly's sphericity test ( Figure   6E ). 
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